These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2844351)

  • 1. Urinary catecholamine metabolite and tribulin output during lactate infusion.
    Clow A; Glover V; Weg MW; Walker PL; Sheehan DV; Carr DB; Sandler M
    Br J Psychiatry; 1988 Jan; 152():122-6. PubMed ID: 2844351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reliability of urinary monoamine and metabolite output measurements in depressed patients.
    Linnoila M; Karoum F; Miller T; Potter WZ
    Am J Psychiatry; 1983 Aug; 140(8):1055-7. PubMed ID: 6191580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoamine metabolism during chronic benzodiazepine treatment and withdrawal.
    Petursson H; Bond PA; Smith B; Lader MH
    Biol Psychiatry; 1983 Feb; 18(2):207-13. PubMed ID: 6187380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tribulin: an endogenous monoamine oxidase inhibitor/benzodiazepine receptor ligand.
    Sandler M; Glover V; Clow A; Elsworth JD
    Prog Clin Biol Res; 1985; 192():359-62. PubMed ID: 3001762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pharmacologic study of the stiff-man syndrome. Correlation of clinical symptoms with urinary 3-methoxy-4-hydroxy-phenyl glycol excretion.
    Schmidt RT; Stahl SM; Spehlmann R
    Neurology; 1975 Jul; 25(7):622-6. PubMed ID: 1171392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of 4-O-methylated catecholamine metabolites in urine by mass fragmentography.
    Muskiet FA; Fremouw-Ottevangers DC; Nagel GT; Wolthers BG
    Clin Chem; 1979 Oct; 25(10):1708-13. PubMed ID: 476919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of theophylline on neurotransmitters in preterm infants with apnea.
    Bhat AM; Scanlon JW; Lavenstein B; Chuang L; Karoum F
    Clin Neuropharmacol; 1983 Mar; 6(1):71-4. PubMed ID: 6133614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and response to sodium lactate of patients with infrequent panic attacks.
    Cowley DS; Dager SR; Foster SI; Dunner DL
    Am J Psychiatry; 1987 Jun; 144(6):795-8. PubMed ID: 3592002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Metabolism of peripheral catecholamines and indole amines in healthy persons. Clinico-biochemical correlates].
    Krzyzowski J; Lewicka-Wysocka H; Lukaszewska B; Marcjan K; Pacyna M; Pietruszewska I; Roguska E; Stencka K
    Pol Tyg Lek; 1981 Mar; 36(11):417-21. PubMed ID: 6167972
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of naloxone on patients with panic attacks.
    Liebowitz MR; Gorman JM; Fyer AJ; Dillon DJ; Klein DF
    Am J Psychiatry; 1984 Aug; 141(8):995-7. PubMed ID: 6087689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactate infusion in anxiety research: its evolution and practice.
    Sheehan DV; Carr DB; Fishman SM; Walsh MM; Peltier-Saxe D
    J Clin Psychiatry; 1985 May; 46(5):158-65. PubMed ID: 3988715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary excretion of catechol metabolites particularly MHPG in children. Relation to age, body mass indices and thyroid function.
    Popa M; Stefănescu AM; Dumitriu L
    Endocrinologie; 1986; 24(3):203-14. PubMed ID: 3775226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity and precursor availability affect urinary catecholamine metabolite production in women.
    Johnston JL; Warsh JJ; Anderson GH
    Am J Clin Nutr; 1983 Sep; 38(3):356-68. PubMed ID: 6613910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary amine metabolite excretion in a patient with adrenergic hyperactivity state: reaction to phenelzine withdrawal and combined treatment.
    Modai I; Beigel Y; Cygielman G
    J Clin Psychiatry; 1986 Feb; 47(2):92-3. PubMed ID: 2418010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship of panic disorder and its treatment outcome to 24-hour urinary MHPG levels.
    Garvey M; Noyes R; Cook B; Tollefson G
    Psychiatry Res; 1989 Oct; 30(1):53-61. PubMed ID: 2594871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the drug treatment of anxiety disorders.
    Pohl R; Rainey JM; Gershon S
    Psychopathology; 1984; 17 Suppl 1():6-14. PubMed ID: 6369369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simple high-performance liquid chromatographic method for the concurrent determination of the amine metabolites vanillylmandelic acid, 3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindoleacetic acid, dihydroxyphenylacetic acid and homovanillic acid in urine using electrochemical detection.
    Joseph MH; Kadam BV; Risby D
    J Chromatogr; 1981 Dec; 226(2):361-8. PubMed ID: 6172439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of neurotransmitters in premature infants with or without apnea of prematurity.
    Bhat AM; Scanlon JW; Lavenstein B; Chuang L; Karoum F
    Clin Neuropharmacol; 1982 Dec; 5(4):389-94. PubMed ID: 6130840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium lactate infusion, panic attacks, and ionized calcium.
    Fyer AJ; Gorman JM; Liebowitz MR; Levitt M; Danielson E; Martinez J; Klein DF
    Biol Psychiatry; 1984 Oct; 19(10):1437-47. PubMed ID: 6518201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of laboratory-induced panic-anxiety on subsequent provocative infusions.
    Yeragani VK; Balon R; Rainey JM; Ortiz A; Berchou R; Lycaki H; Pohl R
    Psychiatry Res; 1988 Feb; 23(2):161-6. PubMed ID: 3363025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.